GLP-1 medications like Wegovy and Zepbound have changed the conversation around medical weight management. But as more people explore these treatments, insurance coverage is becoming increasingly complicated.
Some insurance plans are expanding access, while others are introducing new requirements, increasing out-of-pocket costs, or removing coverage for weight-loss medications altogether.
With changes already taking place in 2026 and additional updates expected in 2027, here’s what patients should know about GLP-1 insurance coverage.
Why Are Insurance Companies Changing GLP-1 Coverage?
GLP-1 medications have become increasingly popular for weight management, creating new challenges for insurance providers and employers.
While research continues to demonstrate the health benefits of these medications, their cost and growing demand have prompted some insurance plans to reconsider how they’re covered.
According to a September 2026 report highlighted by KFF Health News, a survey of large employers found that 60% provided coverage for GLP-1 medications, down from 72% in 2025.
For patients, these changes may mean additional eligibility requirements, higher prescription costs, or the loss of coverage through an employer-sponsored plan.
It’s also important to understand that coverage for a medication used to treat type 2 diabetes isn’t necessarily the same as coverage for weight management. Even when a medication appears on an insurance plan’s drug list, the reason it’s prescribed can affect whether it’s covered.
Medicare Is Expanding Access to Certain GLP-1 Medications
While some private insurance plans are reducing coverage, Medicare introduced a new program in July 2026.
The Medicare GLP-1 Bridge provides eligible Medicare Part D beneficiaries access to certain weight-management medications for a $50 monthly copayment.
Currently, the program includes select formulations of Wegovy, Zepbound, and Foundayo.
The program is scheduled to continue through December 31, 2027, but eligibility is limited. Patients must meet specific health and weight-related criteria, and their healthcare provider may need to complete prior authorization.
Medicare beneficiaries interested in learning more can review eligibility requirements at Medicare.gov.
What Is Changing in Maryland?
Maryland has also taken steps toward expanding access to obesity treatment.
In 2026, Maryland enacted legislation authorizing the state’s Medical Assistance Program (Medicaid) to provide comprehensive obesity treatment coverage beginning January 1, 2027.
This creates an opportunity for expanded treatment access, but it doesn’t automatically guarantee that GLP-1 medications will be covered for every Medicaid recipient.
Implementation and eligibility will depend on decisions by the Maryland Department of Health and applicable program requirements.
For Maryland residents, it’s an important development to watch as additional coverage information becomes available.
What If Your Insurance Stops Covering Your GLP-1 Medication?
If you’re currently taking a GLP-1 medication, changes to your insurance coverage can be frustrating, especially when you’ve established a treatment routine.
Before making changes to your medication, it’s important to understand what your insurance plan will and won’t cover.
Here are a few things to review:
- Check your 2027 prescription benefits. A medication covered in 2026 may have different requirements next year.
- Ask about prior authorization. Some plans require additional documentation or approval before covering a prescription.
- Review alternative medications. Different GLP-1 medications may have different coverage requirements under the same insurance plan.
- Discuss changes with your healthcare provider. If your medication is no longer covered or has become unaffordable, your provider can help you evaluate appropriate next steps.
If your insurance coverage changes, talk to your healthcare provider. There are often alternatives available that are more affordable or ways to keep costs down.
Medical Weight Management Is More Than Medication
GLP-1 medications can be an important part of weight management, but they’re not the only component of care.
Nutrition counseling, monitoring changes in body composition, and ongoing medical support can help patients work toward their health goals, whether or not medication is part of their treatment plan.
At Maryland Weight Care, we recognize that each patient’s needs, medical history, and treatment options are different.
Our team provides personalized medical weight management and nutrition support to help patients understand their options and develop a plan that works for them.
Have questions about your weight-management options?
Schedule an appointment with Maryland Weight Care in Columbia, Maryland, to discuss your goals and available treatment approaches.
Insurance coverage for medications varies by plan and eligibility, but as your medical provider, we will strive to find a plan that is safe, affordable, and effective for you.